Antiretroviral Activity of the Anti‐CD4 Monoclonal Antibody TNX‐355 in Patients Infected with HIV Type 1

Abstract
BackgroundWe wished to determine the safety and anti–human immunodeficiency virus (HIV) type 1 activity of single doses of TNX-355, a humanized IgG4

This publication has 0 references indexed in Scilit: